Feed aggregator

AstraZeneca, Daiichi Sankyo Win First Tumor-Agnostic HER2 FDA Approval for Enhertu

Biospace news - Sun, 08/04/2024 - 02:00
AstraZeneca, Daiichi Sankyo Win First Tumor-Agnostic HER2 FDA Approval for Enhertu 4/8/2024

FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease

Biospace news - Sun, 08/04/2024 - 02:00
FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease 4/8/2024

Opinion: The Next Generation of ADCs Will Improve Cancer Treatment

Biospace news - Sun, 08/04/2024 - 02:00
Opinion: The Next Generation of ADCs Will Improve Cancer Treatment 4/8/2024

Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome

Biospace news - Fri, 07/05/2024 - 02:00
Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome 5/7/2024

Vertex Touts 13% Revenue Jump, Beats Profit Estimates on Strong Cystic Fibrosis Performance

Biospace news - Fri, 07/05/2024 - 02:00
Vertex Touts 13% Revenue Jump, Beats Profit Estimates on Strong Cystic Fibrosis Performance 5/7/2024

AAV Manufacturing Takes Center Stage at ASGCT24

Biospace news - Fri, 07/05/2024 - 02:00
AAV Manufacturing Takes Center Stage at ASGCT24 5/7/2024

ADC Therapeutics Posts Early Phase II Lymphoma Data for Zynlonta as Revenue Drops 5.8%

Biospace news - Fri, 07/05/2024 - 02:00
ADC Therapeutics Posts Early Phase II Lymphoma Data for Zynlonta as Revenue Drops 5.8% 5/7/2024

Preliminary Findings Point to Low Risk of Secondary Cancers from CAR-T Therapies

Biospace news - Fri, 07/05/2024 - 02:00
Preliminary Findings Point to Low Risk of Secondary Cancers from CAR-T Therapies 5/7/2024

FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format

Biospace news - Fri, 07/05/2024 - 02:00
FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format 5/7/2024

ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector

Biospace news - Wed, 06/05/2024 - 02:00
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024

Opinion: Can Ketamine Be Safely Used at Home?

Biospace news - Wed, 06/05/2024 - 02:00
Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024

5 DMD Data Readouts to Watch in 2024

Biospace news - Wed, 06/05/2024 - 02:00
5 DMD Data Readouts to Watch in 2024 5/6/2024

AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases

Biospace news - Wed, 06/05/2024 - 02:00
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024

FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment

Biospace news - Tue, 06/04/2024 - 02:00
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024

Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer

Biospace news - Fri, 05/17/2024 - 02:00
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer 5/17/2024

GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B

Biospace news - Fri, 05/17/2024 - 02:00
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B 5/17/2024

Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts

Biospace news - Fri, 05/17/2024 - 02:00
Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts 5/17/2024

Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul

Biospace news - Fri, 05/17/2024 - 02:00
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul 5/17/2024

EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA

Biospace news - Fri, 05/17/2024 - 02:00
EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA 5/17/2024

Bayer Touts Phase III Results for Menopause Symptom Drug

Biospace news - Fri, 05/17/2024 - 02:00
Bayer Touts Phase III Results for Menopause Symptom Drug 5/17/2024